{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:09:03Z","timestamp":1770163743156,"version":"3.49.0"},"reference-count":53,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"publisher","award":["21K19340"],"award-info":[{"award-number":["21K19340"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JST SPRING","award":["JPMJSP2127"],"award-info":[{"award-number":["JPMJSP2127"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dysregulation of hepatokines has been observed in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), suggesting their involvement in disease progression. In this study, we aimed to investigate the role of \u03b11-acid glycoprotein (AGP), a hepatokine, in the progression of MASLD and to evaluate its potential therapeutic utility. Reanalysis of hepatic RNA sequencing datasets from patients with fatty liver disease showed that expression of the hepatic AGP gene decreased with disease progression. A high-fat diet (HFD)-induced mouse model of MASLD also showed decreased plasma and hepatic AGP levels. Whole-body AGP-knockout (AGP-KO) mice were fed a HFD for 12 weeks. Compared to wild-type mice, AGP-KO mice fed a HFD displayed further exacerbated hepatic steatosis, obesity, adipose tissue inflammation, and impaired glucose tolerance, suggesting a protective role for endogenous AGP against MASLD. Morphological abnormalities of hepatic mitochondria were observed in AGP-KO mice. Human-derived AGP (hAGP) was isolated and purified from plasma fraction V supernatant derived from human blood donations using ion-exchange column chromatography. hAGP exerted a protective effect against palmitate-induced lipotoxicity in hepatocytes, adipocytes, and macrophages. Exogenous administration of hAGP to MASLD mice attenuated disease progression by reducing hepatic mitochondrial dysfunction and adipose tissue inflammation. In conclusion, decreased endogenous AGP levels may contribute to the disease progression of MASLD. AGP has the potential to serve as a novel therapeutic agent against MASLD by targeting both liver and adipose tissue.<\/jats:p>","DOI":"10.1210\/endocr\/bqag009","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:30:27Z","timestamp":1768307427000},"source":"Crossref","is-referenced-by-count":0,"title":["\u03b11-acid Glycoprotein mitigates MASLD progression by modulating liver and adipose tissue function"],"prefix":"10.1210","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6822-0941","authenticated-orcid":false,"given":"Ayano","family":"Nishinoiri","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University , Kumamoto 862-0973 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Tokumaru","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University , Kumamoto 862-0973 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gai","family":"Kanazawa","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University , Kumamoto 862-0973 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhi","family":"Shintani","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University , Kumamoto 862-0973 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Yoshitake","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University , Kumamoto 862-0973 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University , Kumamoto 862-0973 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soyoka","family":"Fukuta","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University , Kumamoto 862-0973 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyuki","family":"Nishimura","sequence":"additional","affiliation":[{"name":"National Institute for Physiological Sciences, National Institutes of Natural Sciences , Okazaki 444-8585 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2587-5458","authenticated-orcid":false,"given":"Motohiro","family":"Nishida","sequence":"additional","affiliation":[{"name":"National Institute for Physiological Sciences, National Institutes of Natural Sciences , Okazaki 444-8585 ,","place":["Japan"]},{"name":"Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University , Fukuoka 812-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8103-651X","authenticated-orcid":false,"given":"Toru","family":"Takeo","sequence":"additional","affiliation":[{"name":"Division of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University , Kumamoto 860-0811 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutics, Kyoto Pharmaceutical University , Kyoto 607-8414 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University , Kumamoto 862-0973 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9268-4144","authenticated-orcid":false,"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University , Kumamoto 862-0973 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"1","key":"2026020306114635300_bqag009-B1","doi-asserted-by":"crossref","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann Hepatol"},{"issue":"4","key":"2026020306114635300_bqag009-B2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"2026020306114635300_bqag009-B3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"35","key":"2026020306114635300_bqag009-B4","doi-asserted-by":"crossref","first-page":"25445","DOI":"10.1074\/jbc.M701549200","article-title":"Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy","volume":"282","author":"Ito","year":"2007","journal-title":"J Biol Chem"},{"issue":"7","key":"2026020306114635300_bqag009-B5","doi-asserted-by":"crossref","first-page":"102377","DOI":"10.1016\/j.clinre.2024.102377","article-title":"Resmetirom's approval: highlighting the need for comprehensive approaches in NASH therapeutics","volume":"48","author":"Alshehade","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"12","key":"2026020306114635300_bqag009-B6","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3390\/biomedicines9121903","article-title":"Hepatokines and non-alcoholic fatty liver disease: linking liver pathophysiology to metabolism","volume":"9","author":"Kim","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"2026020306114635300_bqag009-B7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab"},{"issue":"11","key":"2026020306114635300_bqag009-B8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"2026020306114635300_bqag009-B9","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/jcb.30252","article-title":"Contribution of organokines in the development of NAFLD\/NASH associated hepatocellular carcinoma","volume":"123","author":"Vachher","year":"2022","journal-title":"J Cell Biochem"},{"issue":"11","key":"2026020306114635300_bqag009-B10","doi-asserted-by":"crossref","first-page":"100446","DOI":"10.1016\/j.xcrm.2021.100446","article-title":"Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia","volume":"2","author":"Fukami","year":"2021","journal-title":"Cell Rep Med"},{"issue":"8","key":"2026020306114635300_bqag009-B11","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/diabetes.51.8.2450","article-title":"Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene","volume":"51","author":"Mathews","year":"2002","journal-title":"Diabetes"},{"key":"2026020306114635300_bqag009-B12","doi-asserted-by":"crossref","first-page":"686251","DOI":"10.3389\/fphys.2021.686251","article-title":"Into the labyrinth of the lipocalin \u03b11-acid glycoprotein","volume":"12","author":"Ruiz","year":"2021","journal-title":"Front Physiol"},{"issue":"677","key":"2026020306114635300_bqag009-B13","doi-asserted-by":"crossref","first-page":"eadd3949","DOI":"10.1126\/scitranslmed.add3949","article-title":"An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis","volume":"15","author":"Wang","year":"2023","journal-title":"Sci Transl Med"},{"issue":"7","key":"2026020306114635300_bqag009-B14","doi-asserted-by":"crossref","first-page":"112697","DOI":"10.1016\/j.celrep.2023.112697","article-title":"Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1\/2-PPAR\u03b3-Cd36 pathway","volume":"42","author":"Li","year":"2023","journal-title":"Cell Rep"},{"issue":"6","key":"2026020306114635300_bqag009-B15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2337\/db15-1193","article-title":"The acute-phase protein orosomucoid regulates food intake and energy homeostasis via leptin receptor signaling pathway","volume":"65","author":"Sun","year":"2016","journal-title":"Diabetes"},{"issue":"9","key":"2026020306114635300_bqag009-B16","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s42255-022-00627-4","article-title":"Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis","volume":"4","author":"Zhou","year":"2022","journal-title":"Nat Metab"},{"issue":"11","key":"2026020306114635300_bqag009-B17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2893.2009.01242.x","article-title":"Comparative serum proteomic analysis of patients with acute-on-chronic liver failure: alpha-1-acid glycoprotein maybe a candidate marker for prognosis of hepatitis B virus infection","volume":"17","author":"Ren","year":"2010","journal-title":"J Viral Hepat"},{"issue":"5","key":"2026020306114635300_bqag009-B18","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3892\/etm.2015.2727","article-title":"iTRAQ-based proteomic analysis of hepatic tissues from patients with hepatitis B virus-induced acute-on-chronic liver failure","volume":"10","author":"Peng","year":"2015","journal-title":"Exp Ther Med"},{"issue":"49","key":"2026020306114635300_bqag009-B19","doi-asserted-by":"crossref","first-page":"19595","DOI":"10.1073\/pnas.0709681104","article-title":"Acute-phase protein alpha-1-acid glycoprotein mediates neutrophil migration failure in sepsis by a nitric oxide-dependent mechanism","volume":"104","author":"Mestriner","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"2026020306114635300_bqag009-B20","doi-asserted-by":"crossref","first-page":"30688","DOI":"10.1074\/jbc.M112.353771","article-title":"\u03b1(1)-acid glycoprotein up-regulates CD163 via TLR4\/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress","volume":"287","author":"Komori","year":"2012","journal-title":"J Biol Chem"},{"issue":"5","key":"2026020306114635300_bqag009-B21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.34067\/KID.0000782019","article-title":"\u03b1(1)-acid glycoprotein attenuates adriamycin-induced nephropathy via CD163 expressing macrophage induction","volume":"1","author":"Fujimura","year":"2020","journal-title":"Kidney360"},{"issue":"3","key":"2026020306114635300_bqag009-B22","doi-asserted-by":"crossref","first-page":"167654","DOI":"10.1016\/j.bbadis.2024.167654","article-title":"Deficiency of hepatokine orosomucoid1 aggravates NAFLD progression in mice","volume":"1871","author":"Sun","year":"2025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5","key":"2026020306114635300_bqag009-B23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/db23-0520","article-title":"The hepatokine orosomucoid 2 mediates beneficial metabolic effects of bile acids","volume":"73","author":"Lee","year":"2024","journal-title":"Diabetes"},{"issue":"5","key":"2026020306114635300_bqag009-B24","doi-asserted-by":"crossref","first-page":"e0128330","DOI":"10.1371\/journal.pone.0128330","article-title":"Superovulation using the combined administration of inhibin antiserum and equine chorionic gonadotropin increases the number of ovulated oocytes in C57BL\/6 female mice","volume":"10","author":"Takeo","year":"2015","journal-title":"PLoS One"},{"issue":"572","key":"2026020306114635300_bqag009-B25","doi-asserted-by":"crossref","first-page":"eaba4448","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"issue":"1","key":"2026020306114635300_bqag009-B26","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1038\/s41467-024-50660-y","article-title":"A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma","volume":"15","author":"Jeong","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"2026020306114635300_bqag009-B27","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1038\/s41598-020-68337-z","article-title":"A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein","volume":"10","author":"Watanabe","year":"2020","journal-title":"Sci Rep"},{"key":"2026020306114635300_bqag009-B28","doi-asserted-by":"crossref","unstructured":"Nishinoiri A, Tokumaru K, Kanazawa G, et al \u00a0Supplementary data for \u201c\u03b1(1)-Acid Glycoprotein Mitigates MASLD Progression by Modulating Liver and Adipose Tissue Function\u201d. Figshare; 2025. doi: 10.6084\/m9.figshare.30925175","DOI":"10.1210\/endocr\/bqag009"},{"issue":"12","key":"2026020306114635300_bqag009-B29","doi-asserted-by":"crossref","first-page":"101185","DOI":"10.1016\/j.jhepr.2024.101185","article-title":"Lipid metabolism in MASLD and MASH: from mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep"},{"issue":"4","key":"2026020306114635300_bqag009-B30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1101\/gad.1177604","article-title":"Transcriptional regulatory circuits controlling mitochondrial biogenesis and function","volume":"18","author":"Kelly","year":"2004","journal-title":"Genes Dev"},{"issue":"2","key":"2026020306114635300_bqag009-B31","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/ijms26020788","article-title":"Protection strategies against palmitic acid-induced lipotoxicity in metabolic syndrome and related diseases","volume":"26","author":"Ceja-Galicia","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2026020306114635300_bqag009-B32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMra2032804","article-title":"Reassessing human adipose tissue","volume":"386","author":"Cypess","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"2026020306114635300_bqag009-B33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cmet.2014.05.005","article-title":"Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling","volume":"20","author":"Wernstedt Asterholm","year":"2014","journal-title":"Cell Metab"},{"issue":"2","key":"2026020306114635300_bqag009-B34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2026020306114635300_bqag009-B35","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.3390\/ijms25094901","article-title":"Vitamin D and metabolic dysfunction-associated steatotic liver disease (MASLD): novel mechanistic insights","volume":"25","author":"Aggeletopoulou","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026020306114635300_bqag009-B36","doi-asserted-by":"crossref","first-page":"17329","DOI":"10.1038\/s41598-018-35339-x","article-title":"A downstream molecule of 1,25-dihydroxyvitamin D3, alpha-1-acid glycoprotein, protects against mouse model of renal fibrosis","volume":"8","author":"Bi","year":"2018","journal-title":"Sci Rep"},{"issue":"10","key":"2026020306114635300_bqag009-B37","first-page":"17221","article-title":"Association between vitamin D and non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: results from a meta-analysis","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"2026020306114635300_bqag009-B38","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1038\/emm.2017.307","article-title":"Estrogen weakens muscle endurance via estrogen receptor-p38 MAPK-mediated orosomucoid (ORM) suppression","volume":"50","author":"Sun","year":"2018","journal-title":"Exp Mol Med"},{"issue":"1","key":"2026020306114635300_bqag009-B39","doi-asserted-by":"crossref","first-page":"bqad175","DOI":"10.1210\/endocr\/bqad175","article-title":"A novel tissue-specific insight into sex steroid fluctuations throughout the murine estrous cycle","volume":"165","author":"Unger","year":"2023","journal-title":"Endocrinology"},{"key":"2026020306114635300_bqag009-B40","doi-asserted-by":"crossref","first-page":"572490","DOI":"10.3389\/fendo.2020.572490","article-title":"Non-alcoholic fatty liver disease as a canonical example of metabolic inflammatory-based liver disease showing a sex-specific prevalence: relevance of estrogen signaling","volume":"11","author":"Della Torre","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2026020306114635300_bqag009-B41","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"2026020306114635300_bqag009-B42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3350\/cmh.2013.19.3.210","article-title":"Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis","volume":"19","author":"Koo","year":"2013","journal-title":"Clin Mol Hepatol"},{"issue":"42","key":"2026020306114635300_bqag009-B43","doi-asserted-by":"crossref","first-page":"30028","DOI":"10.1074\/jbc.274.42.30028","article-title":"Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus","volume":"274","author":"Shimomura","year":"1999","journal-title":"J Biol Chem"},{"issue":"4","key":"2026020306114635300_bqag009-B44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies","volume":"28","author":"Sunny","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"2026020306114635300_bqag009-B45","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00535-025-02257-5","article-title":"Abnormalities of intracellular organelles in metabolic dysfunction-associated steatotic disease","volume":"60","author":"Kido","year":"2025","journal-title":"J Gastroenterol"},{"key":"2026020306114635300_bqag009-B46","doi-asserted-by":"crossref","first-page":"107422","DOI":"10.1016\/j.phrs.2024.107422","article-title":"Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke","volume":"209","author":"Jing","year":"2024","journal-title":"Pharmacol Res"},{"issue":"2","key":"2026020306114635300_bqag009-B47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7570\/jomes25025","article-title":"Human adipose tissue metabolism in obesity","volume":"34","author":"Lin","year":"2025","journal-title":"J Obes Metab Syndr"},{"issue":"4","key":"2026020306114635300_bqag009-B48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/exd.14718","article-title":"CCL6 promotes M2 polarization and inhibits macrophage autophagy by activating PI3-kinase\/Akt signalling pathway during skin wound healing","volume":"32","author":"Feng","year":"2023","journal-title":"Exp Dermatol"},{"issue":"7","key":"2026020306114635300_bqag009-B49","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2337\/db11-1506","article-title":"CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1\/M2 status","volume":"61","author":"Kitade","year":"2012","journal-title":"Diabetes"},{"issue":"6","key":"2026020306114635300_bqag009-B50","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/hep.32458","article-title":"C-C motif chemokine ligand 5 confines liver regeneration by down-regulating reparative macrophage-derived hepatocyte growth factor in a forkhead box O 3a-dependent manner","volume":"76","author":"Huang","year":"2022","journal-title":"Hepatology"},{"key":"2026020306114635300_bqag009-B51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ebiom.2017.09.008","article-title":"Transcriptome analysis uncovers a growth-promoting activity of orosomucoid-1 on hepatocytes","volume":"24","author":"Qin","year":"2017","journal-title":"EBioMedicine"},{"issue":"9","key":"2026020306114635300_bqag009-B52","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1210\/en.2009-0221","article-title":"Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity","volume":"150","author":"Berglund","year":"2009","journal-title":"Endocrinology"},{"issue":"1","key":"2026020306114635300_bqag009-B53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12951-022-01456-z","article-title":"A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease","volume":"20","author":"Hu","year":"2022","journal-title":"J Nanobiotechnology"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqag009\/66420898\/bqag009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/2\/bqag009\/66420898\/bqag009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/2\/bqag009\/66420898\/bqag009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T11:12:00Z","timestamp":1770117120000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqag009\/8426308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,8]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqag009","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,8]]},"article-number":"bqag009"}}